Practical Challenges in Maintenance Therapy for NSCLC: A Nursing Perspective Part 2
Description: Histological subtypes of NSCLC are no longer treated alike as a result of emerging evidence differentiating optimal treatment paradigms based on histology. With the advent of well-tolerated, chemotherapeutic and targeted agents, the standard of care for patients with NSCLC continues to evolve particularly in the first-line and maintenance settings. These clinical advances and recent data have led to improved patient survival; however, effective management of patients with lung cancer continues to pose a considerable challenge. As the biology of lung cancer is better understood, data matures, and treatment options expand, it is imperative that nurses stay abreast of updates.
This symposium covered both an expert lecture and interactive roundtable case discussions. The expert lecture will include issues related to histology, biomarker testing, first-line therapy, maintenance therapy, symptom management, and survivorship care. The case discussions will address the influence of clinical progression and symptom management on treatment planning. The faculty panel will provide expert recommendations on management of each patient case.
This recording was originally presented as an educational symposia during the ONS 12th Annual Institutes of Learning in Salt Lake City. To receive CE credit for this activity visit: imeronline.com/nsclc_iol_812
Teresa J. Knoop, MSN, RN, AOCN® (Chairperson)
Vanderbilt-Ingram Cancer Center
Megan Dunne, MA, RN, APRN-BC, AOCN®
Memorial Sloan-Kettering Cancer Center
Howard (Jack) L. West, MD
Swedish Cancer Institute
Shared By : imeronline
Posted on : 11/08/11
Added : 7 years ago